Toloxatone
From Wikipedia, the free encyclopedia
![]() |
|
Systematic (IUPAC) name | |
---|---|
5-(hydroxymethyl)-3-m-tolyloxazolidin-2-one
|
|
Clinical data | |
Routes of administration |
Oral |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | 29218-27-7 ![]() |
ATC code | N06AG03 (WHO) |
PubChem | CID 34521 |
ChemSpider | 31769 ![]() |
UNII | 5T206015T5 ![]() |
KEGG | D02559 ![]() |
ChEMBL | CHEMBL18116 ![]() |
Chemical data | |
Formula | C11H13NO3 |
Molar mass | 207.226 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
![]() ![]() |
Toloxatone (Humoryl) is an antidepressant launched in 1984 in France for the treatment of depression. It acts as a selective reversible inhibitor of MAO-A (RIMA).[1]
See also[edit]
References[edit]
- ^ Berlin I, Zimmer R, Thiede HM, et al. (December 1990). "Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects". British Journal of Clinical Pharmacology. 30 (6): 805–16. doi:10.1111/j.1365-2125.1990.tb05445.x. PMC 1368300
. PMID 1705137.
![]() |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |